Clinical relevance of distinguishing autoimmune nodopathies from CIDP: longitudinal assessment in a large cohort

Abstract

Distinguishing CIDP from AN is important, as patients with AN need a different treatment approach. Improvement and relapses were associated with changes in antibody titres, supporting the pathogenicity of these antibodies.